Template:Streptococcal Pharyngitis Antibiotics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
''Treatment can be delayed for up to 9 days and still prevent major sequelae'' | ''Treatment can be delayed for up to 9 days and still prevent major sequelae'' | ||
'''[[Penicillin]] Options:<ref>Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82</ref>''' | '''[[Penicillin]] Options:<ref name=Shulman12>Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82</ref>''' | ||
*[[Penicillin V]] 250mg PO BID x 10d (child) or 500mg BID x 10d (adolescent or adult) | *[[Penicillin V]] 250mg PO BID x 10d (child) or 500mg BID x 10d (adolescent or adult) | ||
*[[Bicillin L-A]] <27 kg: 0.6 million units; ≥27 kg: 1.2 million units IM x 1 | *[[Bicillin L-A]] <27 kg: 0.6 million units; ≥27 kg: 1.2 million units IM x 1 | ||
'''[[Penicillin]] allergic (mild):<ref>Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82</ref>''' | '''[[Penicillin]] allergic (mild):<ref name=Shulman12>Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82</ref>''' | ||
*[[Cefuroxime]] 10mg/kg PO QID x 10d (child) or 250mg PO BID x 4d | *[[Cefuroxime]] 10mg/kg PO QID x 10d (child) or 250mg PO BID x 4d | ||
'''[[Penicillin]] allergic (anaphylaxis):<ref>Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82</ref>''' | '''[[Penicillin]] allergic (anaphylaxis):<ref name=Shulman12>Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82</ref>''' | ||
*[[Clindamycin]] 7.5mg/kg PO QID x 10d (child) or 450mg PO TID x 10d OR | *[[Clindamycin]] 7.5mg/kg PO QID x 10d (child) or 450mg PO TID x 10d OR | ||
*[[Azithromycin]] 12mg/kg QD (child) or 500mg on day 1; then 250mg on days 2-5 | *[[Azithromycin]] 12mg/kg QD (child) or 500mg on day 1; then 250mg on days 2-5 | ||
Revision as of 01:05, 18 May 2019
Treatment can be delayed for up to 9 days and still prevent major sequelae
Penicillin Options:[1]
- Penicillin V 250mg PO BID x 10d (child) or 500mg BID x 10d (adolescent or adult)
- Bicillin L-A <27 kg: 0.6 million units; ≥27 kg: 1.2 million units IM x 1
Penicillin allergic (mild):[1]
- Cefuroxime 10mg/kg PO QID x 10d (child) or 250mg PO BID x 4d
Penicillin allergic (anaphylaxis):[1]
- Clindamycin 7.5mg/kg PO QID x 10d (child) or 450mg PO TID x 10d OR
- Azithromycin 12mg/kg QD (child) or 500mg on day 1; then 250mg on days 2-5